Microbiome Differences in Colorectal Cancer Patients and Healthy Individuals: Implications for Vaccine Antigen Discovery
GC Ibeanu, AB Rowaiye, JC Okoli… - ImmunoTargets and …, 2024 - Taylor & Francis
Background Colorectal cancer (CRC) is the third most prevalent cancer worldwide, with
numerous risk factors contributing to its development. Recent research has illuminated the …
numerous risk factors contributing to its development. Recent research has illuminated the …
Exploring Gut Microbiome Composition and Circulating Microbial DNA Fragments in Patients with Stage II/III Colorectal Cancer: A Comprehensive Analysis
I Messaritakis, A Koulouris, E Boukla, K Vogiatzoglou… - Cancers, 2024 - mdpi.com
Simple Summary This study delves into how the community of microorganisms residing in
the gut, known as the gut microbiome, can aid in understanding and predicting colorectal …
the gut, known as the gut microbiome, can aid in understanding and predicting colorectal …
Biological Evaluation of Lysionotin: a Novel Inhibitor of 5-Lipoxygenase for Anti-glioma
X Shao, C Chen, J Liu, Q Li, S He, XH Qi, X Fu… - Chinese Journal of …, 2024 - Springer
Objective To explore the potential mechanism of lysionotin in treating glioma. Methods First,
target prediction based on Bernoulli Naïve Bayes profiling and pathway enrichment was …
target prediction based on Bernoulli Naïve Bayes profiling and pathway enrichment was …